• 'STIC-like' lesions in ovarian low-grade serous carcinoma: a diagnostic pitfall
• 3D laparoscopic treatment of bladder cancer with pelvic multi-organ invasion: a case report and literature review
• A case of low-grade intestinal-type mucinous neoplasm of the fallopian tube with KRAS exon 2 mutation
• A Cellular atlas of the human fallopian tube reveals the metamorphosis of secretory epithelial cells during the menstrual cycle and menopause
• A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283
• A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
• A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors
• A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
• A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers
• A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy
• A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine
• A unilateral twin ectopic pregnancy in the fallopian tube: A rare case report
• Added value of regional ¹⁸F-FDG PET/MRI-assisted whole-body ¹⁸F-FDG PET/CT in malignant ascites with unknown primary origin
• Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists
• AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial
• An Integrated Approach to Protein Discovery and Detection From Complex Biofluids
• An Unusual Case of Extranodal Marginal Zone Lymphoma Mimicking Abdominal Cocoon Syndrome in an Adolescent Patient
• An Unusual Presentation: High-Grade Serous Carcinoma of the Fallopian Tube Manifesting with Altered Mental Status Secondary to a Single Brain Metastasis - A Case Report and Review of The Literature
• Aneuploidy Landscape in Precursors of Ovarian Cancer
• ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer
• Assessment of Fallopian Tube Epithelium Features Derived from Induced Pluripotent Stem Cells of Both Fallopian Tube and Skin Origins
• Association between vaginal bleeding in pregnancy that resulted in delivery and risk of cancer: A Danish registry-based cohort study
• Bilateral salpingectomy as an option of permanent contraception at time of caesarean section: A survey of practice
• BRCA1/2 reversion mutations in a pan-cancer cohort
• CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR
• CD133/Prom1 marks proximal mouse oviduct epithelial progenitors and adult epithelial cells with a low generative capacity
• Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment
• Characterization of adnexal lesions using photoacoustic imaging to improve ultrasound O-RADS risk assessment
• Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
• Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation
• Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review
• Early-stage serous fallopian tube carcinoma
• Early-Stage, BRCA-Associated Ovarian Cancer Detected by Papanicolaou Smear: A Case Report
• Effects of Follicular Fluid on Physiological Characteristics and Differentiation of Fallopian Tube Epithelial Cells Implicating for Ovarian Cancer Pathogenesis
• Effects of intermittent fasting on quality of life tolerance of chemotherapy in patients with gynecological cancers: study protocol of a randomized-controlled multi-center trial
• Effects of the Overexpression of Progesterone Receptors on a Precancer p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line
• Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment
• Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review
• Facial pyoderma gangrenosum associated with fallopian tube carcinosarcoma
• Fallopian tube cytology as a diagnostic tool for adnexal malignancy: the CytoSaLPs score
• Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis
• Gain-of-function p53^R175H blocks apoptosis in a precursor model of ovarian high-grade serous carcinoma
• Gefitinib and methotrexate to resolve tubal ectopic pregnancy: the GEM3 RCT
• Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects
• HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor
• Hereditary breast and ovarian cancer triggered by occult fallopian tube cancer: a case report
• High-grade serous ovarian carcinoma, the "Achiles' hill" for clinicians and molecular biologists: a molecular insight
• Histopathological Findings of Ectopic Pregnancy in Contraceptive-Wearing Woman
• Identification of fallopian tube microbiota and its association with ovarian cancer: a prospective study of intraoperative swab collections from 187 patients
• Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer Patients
• Imaging of a Pelvic Mass: Adnexal
• Imaging of a Pelvic Mass: Uterine
• Inaugurating High-Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection
• Inguinal Lymph Node Metastasis as Sole Manifestation of Ovarian / Fallopian Tube Cancer: a Review of the Literature
• Insulin-like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high-grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects
• Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas
• Interferon-ε is a tumour suppressor and restricts ovarian cancer
• Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study
• Isolated torsion of fallopian tube with associated torsed paratubal cystadenofibroma: A case report
• Iterative prototyping based on lessons learned from the falloposcope <em>in vivo</em> pilot study experience
• LAMA5 promotes cell proliferation and migration in ovarian cancer by activating Notch signaling pathway
• LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma
• Malignant germ cell tumor of fallopian tube with rhabdomyosarcoma: a case report and literature review
• Management of a Nulliparous IVF Patient with a Declined Ovarian Reserve After Discovery of an Atypical Ovarian Endometriotic Cyst
• Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations
• Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo
• Nanomedicines for Improved Management of Ectopic Pregnancy: A Narrative Review
• News Brief: To prevent ovarian cancer, women should consider prophylactic removal of fallopian tubes
• OCRA encourages fallopian tube removal for women undergoing pelvic surgeries for benign conditions
• OS and DFS are affected by different diagnostic methods and hysterectomy procedures in endometrial cancer patients: A single-center retrospective study
• OvaPrint™ - a cell-free DNA methylation liquid biopsy for the risk assessment of high-grade serous ovarian cancer
• Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy
• Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas
• Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
• Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer Society
• Positive Rate of Malignant Cells in Endometrial Cytology Samples of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Patients: A Systematic Review and Meta-Analysis
• Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer
• Precision-engineered biomimetics: the human fallopian tube
• Prevalence of active cytomegalovirus infection at diagnosis of ovarian cancer and during chemotherapy and subsequent changes in cognitive functioning
• Primary Retroperitoneal Carcinomas: New Insights into Pathogenesis and Clinical Management in Comparison with Ovarian Carcinomas and Carcinoma of Unknown Primary
• Probing the Cytotoxic Signaling Induced by Eupenifeldin in Ovarian Cancer Models
• Rare non-serous fallopian tube cancers: institutional experience and literature review
• Rationale and Methodologic Approach for Assessing Ovarian Cancer Treatment and Gynecologic Oncologist Involvement in the Midwest Region of the United States
• Re-evaluating the role of progesterone in ovarian cancer: is progesterone always protective?
• Reevaluating the Role of Progesterone in Ovarian Cancer: Is Progesterone Always Protective?
• Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study
• Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer
• Retroperitoneal Hematoma as an Atypical Presentation of Choriocarcinoma: A Case Report
• Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer
• Role of LRRN4 in promoting malignant behavior in a p53- and Rb-defective human fallopian tube epithelial cell line
• Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context
• Salpingectomy and the Risk of Ovarian Cancer in Ontario
• Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review
• Same day service: A genetic testing station model to improve germline genetic testing in patients with ovarian cancer
• Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids
• The haunting diagnosis of malignancy in women with treatable reproductive system tuberculosis
• Tubal adenocarcinoma: Report of 3 cases and review of the literature
• Undiagnosed uterus didelphys with unicavitary twin gestation in a district hospital in Ghana: a case report
• Vaginal Bacteria Elicit Acute Inflammatory Response in Fallopian Tube Organoids
• Vaginal bacteria elicit acute inflammatory response in fallopian tube organoids: a model for pelvic inflammatory disease